| Basics |
Quidel Corporation
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.
|
| IPO Date: |
February 1, 1991 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.89B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.91 | 1.99%
|
| Avg Daily Range (30 D): |
$0.73 | 2.94%
|
| Avg Daily Range (90 D): |
$0.73 | 2.78%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.39M |
| Avg Daily Volume (30 D): |
1.32M |
| Avg Daily Volume (90 D): |
1.17M |
| Trade Size |
| Avg Trade Size (Sh.): |
76 |
| Avg Trade Size (Sh.) (30 D): |
63 |
| Avg Trade Size (Sh.) (90 D): |
61 |
| Institutional Trades |
| Total Inst.Trades: |
5,635 |
| Avg Inst. Trade: |
$3.32M |
| Avg Inst. Trade (30 D): |
$3M |
| Avg Inst. Trade (90 D): |
$2.89M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.33M |
| Avg Closing Trade (30 D): |
$4.55M |
| Avg Closing Trade (90 D): |
$4.55M |
| Avg Closing Volume: |
76.37K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-17.41
|
$-10.78
|
$-3.77
|
|
Diluted EPS
|
$-17.41
|
$-10.78
|
$-3.77
|
|
Revenue
|
$ 2.71B
|
$ 699.9M
|
$ 613.9M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -1179.5M
|
$ -733M
|
$ -255.4M
|
|
Operating Income / Loss
|
$ -953.3M
|
$ -704.8M
|
$ -180.7M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -45.9M
|
$ -53.6M
|
$ 24.5M
|
|
PE Ratio
|
|
|
|
|
|
|
